A specific group of nerve cells in the brain stem appears to control how semaglutide affects appetite and weight — without causing nausea. The discovery, made at the University of Gothenburg, could pave the way for better drugs to treat obesity.
Semaglutide belongs to a group of drugs called GLP-1R agonists and has been shown to effectively reduce food intake and body weight. The drug is already well established as part of the treatment for obesity and type 2 diabetes, but can cause side…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply